financetom
Business
financetom
/
Business
/
Jindal Stainless posts Rs 86.5 cr net loss in Q1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jindal Stainless posts Rs 86.5 cr net loss in Q1
Sep 8, 2020 8:05 AM

Jindal Stainless Ltd (JSL) on Tuesday posted a net loss of Rs 86.50 crore during the quarter ended June 30, mainly on account of reduced income. The company had reported a net profit of Rs 66.83 crore during the same quarter a year ago, JSL said in a BSE filing.

During April-June, the company’s total income plunged to Rs 1,271.75 crore from Rs 3,076.43 crore in the year-ago quarter. Total expenses during the period under review stood at Rs 1,410.04 crore as against Rs 2,995.61 crore a year ago.

JSL recorded a loss primarily on account of COVID-19 pandemic-induced business environment, it said in a statement. With the gradual easing of nationwide lockdown in May-June, JSL’s operations have been inching towards normalcy, it said.

”Domestic stainless steel industry was no exception to the slowdown caused by COVID-19. For JSL too, it was an unprecedented quarter, with operations completely suspended in April,” JSL Managing Director Abhyuday Jindal was quoted as saying in the statement. The company has undertaken several business, operational, and strategic initiatives to minimise the impact of the pandemic, and hopes to recover by the end of September with improved business sentiments, he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Arcturus Therapeutics ( ARCT ) slumped more than 29% in Friday trading, despite reporting positive preliminary data from phase 1 and phase 1b study of its ARCT-032 prospective treatment for cystic fibrosis. Appearing at an industry conference in Glasgow, Scotland, executives of the the messenger RNA medicines and vaccines company said the inhaled...
Bakkt Holdings Explores Potential Sale Or Breakup Amid Crypto Sector Consolidation
Bakkt Holdings Explores Potential Sale Or Breakup Amid Crypto Sector Consolidation
Jun 7, 2024
Bakkt Holdings Inc. ( BKKT/WS ) shares are trading lower Friday afternoon after reports emerged that the company is exploring a potential sale or breakup. This move comes amid increased consolidation activity in the digital-asset sector and near-record high crypto prices. What’s Going On: According to a Bloomberg report, Bakkt Holdings Inc. ( BKKT/WS ), the digital-asset marketplace established by...
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Kevin J McNamara, Director, President and CEO, on June 06, 2024, sold 1,500 shares in Chemed ( CHE ) for $816,255. Following the Form 4 filing with the SEC, McNamara has control over a total of 107,049 shares of the company, with 107,049 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19584/000095017024070509/xslF345X03/ownership.xml Price: 544.96, Change: +0.79,...
Why Are Venus Concept Shares Moving
Why Are Venus Concept Shares Moving
Jun 7, 2024
Venus Concept Inc. ( VERO ) shares are experiencing a surge in trading activity Friday due to the company’s recent announcement that it has regained compliance with Nasdaq’s minimum equity rule. What To Know: Venus Concept ( VERO ) saw its stock price soar by 126.7% in pre-market trading on Friday on continued momentum after the announcement on Thursday. This...
Copyright 2023-2026 - www.financetom.com All Rights Reserved